by Karen Matthias, MBA, RN, Vice President, Sales and Marketing
We all have family members or know others who suffer from some degree of coronary artery disease (CAD). Did you know that this is the most common type of heart disease and is the leading cause of death in the United States for both men and women?
Treating CAD involves improving blood flow to the heart by opening up blocked arteries or replacing diseased arteries with healthy vessels from another part of the body in a procedure known as coronary artery bypass grafting (CABG), commonly referred to as open heart surgery. Minimally invasive coronary artery bypass grafting (MI-CABG) techniques have been introduced as alternatives in order to improve patient outcomes.
We recently completed a health technology assessment on MI-CABG techniques and examined these relevant questions:
- Are MI-CABG techniques effective in decreasing the need for repeat revascularization, reducing major adverse cardiac events, and preventing recurrence of angina?
- How do the results of MI-CABG compare with those of other revascularization procedures?
- Is MI-CABG safe?
- Have definitive patient selection criteria been established for MI-CABG for treatment of symptomatic CAD?
Our research indicates that this new type of surgery (MI-CABG) may be safe and feasible for patients who are considered to be at low risk. This might be those who experience chest pain due to a large blockage in one of their coronary arteries. However, more definitive information is needed to determine how well it compares with other traditional heart surgeries in terms of patient morbidity and mortality.
Hayes clients can access this report, along with the Hayes Rating applied to this technology, through our Knowledge Center. If you are not a Hayes client, but would like to purchase a single copy of this report, please contact us.